211 related articles for article (PubMed ID: 33198164)
1. Multiple Sclerosis: Shall We Target CD33?
Siokas V; Tsouris Z; Aloizou AM; Bakirtzis C; Liampas I; Koutsis G; Anagnostouli M; Bogdanos DP; Grigoriadis N; Hadjigeorgiou GM; Dardiotis E
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198164
[TBL] [Abstract][Full Text] [Related]
2. CD33 rs3865444 as a risk factor for Parkinson's disease.
Siokas V; Arseniou S; Aloizou AM; Tsouris Z; Liampas I; Sgantzos M; Liakos P; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
Neurosci Lett; 2021 Mar; 748():135709. PubMed ID: 33582190
[TBL] [Abstract][Full Text] [Related]
3. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
4. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
[TBL] [Abstract][Full Text] [Related]
5. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease?
Siokas V; Aslanidou P; Aloizou AM; Peristeri E; Stamati P; Liampas I; Arseniou S; Drakoulis N; Aschner M; Tsatsakis A; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Mol Neurosci; 2020 Jun; 70(6):851-860. PubMed ID: 32088842
[TBL] [Abstract][Full Text] [Related]
6. Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.
Malik M; Chiles J; Xi HS; Medway C; Simpson J; Potluri S; Howard D; Liang Y; Paumi CM; Mukherjee S; Crane P; Younkin S; Fardo DW; Estus S
Hum Mol Genet; 2015 Jun; 24(12):3557-70. PubMed ID: 25762156
[TBL] [Abstract][Full Text] [Related]
7. CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer's Disease.
Heidari F; Ansstas G; Ajamian F
Gerontology; 2022; 68(4):421-430. PubMed ID: 34569532
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Disease Risk Variant rs3865444 in the
Javor J; Bucová M; Ďurmanová V; Radošinská D; Párnická Z; Čierny D; Kurča E; Čopíková-Cudráková D; Gmitterová K; Shawkatová I
Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888182
[TBL] [Abstract][Full Text] [Related]
9. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility.
Raj T; Ryan KJ; Replogle JM; Chibnik LB; Rosenkrantz L; Tang A; Rothamel K; Stranger BE; Bennett DA; Evans DA; De Jager PL; Bradshaw EM
Hum Mol Genet; 2014 May; 23(10):2729-36. PubMed ID: 24381305
[TBL] [Abstract][Full Text] [Related]
10. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.
Walker DG; Whetzel AM; Serrano G; Sue LI; Beach TG; Lue LF
Neurobiol Aging; 2015 Feb; 36(2):571-82. PubMed ID: 25448602
[TBL] [Abstract][Full Text] [Related]
11. Lack of Association between
Siokas V; Liampas I; Aloizou AM; Bakirtzis C; Tsouris Z; Nousia A; Nasios G; Papadimitriou D; Lavdas E; Liakos P; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Integr Neurosci; 2023 Jul; 22(4):106. PubMed ID: 37519183
[TBL] [Abstract][Full Text] [Related]
12. CD33 rs3865444 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Chinese, European, and North American Populations.
Li X; Shen N; Zhang S; Liu J; Jiang Q; Liao M; Feng R; Zhang L; Wang G; Ma G; Zhou H; Chen Z; Jiang Y; Zhao B; Li K; Liu G
Mol Neurobiol; 2015 Aug; 52(1):414-21. PubMed ID: 25186233
[TBL] [Abstract][Full Text] [Related]
13. CD33 polymorphisms and Parkinson's disease Parkinson's disease in northern Chinese Han population: A case-control study.
Tian Q; Sun X; Li C; Yang Y; Hou B; Xie A
Neurosci Lett; 2023 Aug; 812():137400. PubMed ID: 37479176
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease.
Deng YL; Liu LH; Wang Y; Tang HD; Ren RJ; Xu W; Ma JF; Wang LL; Zhuang JP; Wang G; Chen SD
Hum Genet; 2012 Jul; 131(7):1245-9. PubMed ID: 22382309
[TBL] [Abstract][Full Text] [Related]
15. Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations.
Mao YF; Guo ZY; Pu JL; Chen YX; Zhang BR
Neurosci Lett; 2015 Nov; 609():235-9. PubMed ID: 26455864
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.
Griciuc A; Serrano-Pozo A; Parrado AR; Lesinski AN; Asselin CN; Mullin K; Hooli B; Choi SH; Hyman BT; Tanzi RE
Neuron; 2013 May; 78(4):631-43. PubMed ID: 23623698
[TBL] [Abstract][Full Text] [Related]
17. CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.
Lamba JK; Chauhan L; Shin M; Loken MR; Pollard JA; Wang YC; Ries RE; Aplenc R; Hirsch BA; Raimondi SC; Walter RB; Bernstein ID; Gamis AS; Alonzo TA; Meshinchi S
J Clin Oncol; 2017 Aug; 35(23):2674-2682. PubMed ID: 28644774
[TBL] [Abstract][Full Text] [Related]
18. Variant of
Chen S; Zhang J; Liu QB; Zhuang JC; Wu L; Xu YF; Li HF; Wu ZY; Xiao BG
Chin Med J (Engl); 2018 Mar; 131(6):643-647. PubMed ID: 29521285
[TBL] [Abstract][Full Text] [Related]
19. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
Murch SH
Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
[TBL] [Abstract][Full Text] [Related]
20. The CD33 genotype associated cognitive performance was bidirectionally modulated by intrinsic functional connectivity in the Alzheimer's disease spectrum.
Gong L; Xu R; Lan L; Liu D; Shen J; Zhang B;
Biomed Pharmacother; 2019 Jul; 115():108903. PubMed ID: 31054508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
